Literature DB >> 204229

In vitro antiviral efficacy of ribavirin against feline calicivirus, feline viral rhinotracheitis virus, and canine parainfluenza virus.

R C Povey.   

Abstract

Ribavirin had marked in vitro activity against feline calcivirus, strain 255, and canine parainfluenza virus, but showed only slight antiviral effect on feline viral rhinotracheitis virus. Antiviral activity was manifested by partial to complete suppression of viral cytopathic effect and of viral replication, depending on concentration of ribavirin in the culture medium and dosage of viral inoculum. Concentrations of ribavirin as small as 3.2 microgram/ml and 1.0 microgram/ml showed some activity against feline calcivirus and canine parainfluenza virus, respectively.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 204229

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN： 0002-9645            Impact factor:   1.156


  18 in total

1.  Norovirus proteinase-polymerase and polymerase are both active forms of RNA-dependent RNA polymerase.

Authors:  Gaël Belliot; Stanislav V Sosnovtsev; Kyeong-Ok Chang; Vijay Babu; Uzo Uche; Jamie J Arnold; Craig E Cameron; Kim Y Green
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

2.  Comparative immunological characterization of type-specific and conserved B-cell epitopes of pinniped, felid and canid herpesviruses.

Authors:  M Lebich; T C Harder; H R Frey; I K Visser; A D Osterhaus; B Liess
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

3.  Clinical presentation and management of suspected ribavirin toxicosis in a dog.

Authors:  Kimberly Bridges; Nicole Beckel; Claire Sharp; Laura Stern
Journal:  Can Vet J       Date:  2016-05       Impact factor: 1.008

4.  Aqueous Extracts of Hibiscus sabdariffa Calyces Decrease Hepatitis A Virus and Human Norovirus Surrogate Titers.

Authors:  Snehal S Joshi; Lezlee Dice; Doris H D'Souza
Journal:  Food Environ Virol       Date:  2015-07-05       Impact factor: 2.778

Review 5.  Ribavirin: a clinical overview.

Authors:  H Fernandez; G Banks; R Smith
Journal:  Eur J Epidemiol       Date:  1986-03       Impact factor: 8.082

6.  Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent.

Authors:  J J Kirsi; J A North; P A McKernan; B K Murray; P G Canonico; J W Huggins; P C Srivastava; R K Robins
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

Review 7.  Ribavirin and inosiplex: a review of their present status in viral diseases.

Authors:  T W Chang; R C Heel
Journal:  Drugs       Date:  1981-08       Impact factor: 9.546

8.  Effects of ribavirin on BHK-21 cells acutely or persistently infected with mumps virus.

Authors:  J R McCammon; V W Riesser
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

9.  Interferons and ribavirin effectively inhibit Norwalk virus replication in replicon-bearing cells.

Authors:  Kyeong-Ok Chang; David W George
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

10.  Susceptibility of feline herpesvirus 1 and a feline calicivirus to feline interferon and recombinant human leukocyte interferons.

Authors:  R W Fulton; L J Burge
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.